Home - Products - Microbiology/Virology - Antifungal - SQLE-IN-1

SQLE-IN-1

CAS No. 1019169-83-5

SQLE-IN-1( —— )

Catalog No. M37352 CAS No. 1019169-83-5

SQLE-IN-1 is a squalene epoxidase (SQLE) inhibitor with anti-tumor activity.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	141	Get Quote
5MG	217	Get Quote
10MG	353	Get Quote
25MG	670	Get Quote
50MG	1067	Get Quote
100MG	1557	Get Quote
500MG	Get Quote	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

SQLE-IN-1
Note

Research use only, not for human use.
Brief Description

SQLE-IN-1 is a squalene epoxidase (SQLE) inhibitor with anti-tumor activity.
Description

SQLE-IN-1 is a squalene epoxidase (SQLE) inhibitor with anti-tumor activity. It can inhibit the proliferation and migration of liver cancer cell line Huh7, inhibit the production of cellular cholesterol, and increase the expression of the tumor suppressor gene PTEN. expression, inhibiting the protein expression of PI3K and AKT.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Microbiology/Virology
Target

Antifungal
Recptor

Antifungal
Research Area

——
Indication

——

Chemical Information

CAS Number

1019169-83-5
Formula Weight

481.52
Molecular Formula

C24H21F2N5O2S
Purity

>98% (HPLC)
Solubility

——
SMILES

O=S(=O)(NC1=CC=C(C=C1)NC=2N=C(N=C(C2)NC3=CC=C(C=C3)C)C)C4=CC=C(F)C=C4F
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

LW3

LW3 is an effective broad-spectrum antifungal compound. LW3 showed antifungal activity against B. cinerea, R. solani, S. sclerotiorum and F. graminearum, with EC50 values of 0.54, 0.09, 1.52 and 2.65 mg/L, respectively.
Levobetaxolol HCl

Levobetaxolol hydrochloride is a beta-adrenergic receptor inhibitor (beta blocker), used to lower the pressure in the eye in treating conditions such as glaucoma.
APX2039

APX2039 is an orally active fungal Gwt1 enzyme inhibitor and a prodrug of the novel Gwt2096 inhibitor APX1.APX2039 exhibits potent anti-Kryptococcal activity against C. neoformans and C. gattii.

Sign In Join Free